Taiyen Biotech Co., Ltd.

TWSE:1737 Stock Report

Market Cap: NT$6.5b

Taiyen Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1737?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders24,3910.0122%
Private Companies14,161,3377.08%
Institutions24,284,03912.1%
State or Government77,768,27238.9%
General Public83,761,96141.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 19 shareholders own 58.12% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
38.9%
Ministry of Economic Affairs, R.O.C
77,768,272NT$2.5b0%no data
5%
Tung Wei Construction Co., Ltd.
9,998,000NT$322.4m0%no data
3.27%
CTBC Securities Investment Trust Co., Ltd.
6,534,592NT$210.7m0%0.19%
2.21%
The Vanguard Group, Inc.
4,421,856NT$142.6m0%no data
1.42%
Dimensional Fund Advisors LP
2,841,610NT$91.6m0%no data
1.3%
South China Yongchang Securities Investment Trust Co., Ltd.
2,609,000NT$84.1m0%0.44%
1.3%
State Street Global Advisors, Inc.
2,592,479NT$83.6m4.68%no data
1.06%
IBF Financial Holdings Co., Ltd., Asset Management Arm
2,116,000NT$68.2m0%27.42%
1.01%
KGI Securities Investment Trust Co., Ltd.
2,028,041NT$65.4m0%0.1%
0.98%
Global Cargo Organization & Company Ltd.
1,966,000NT$63.4m0%no data
0.7%
Ming Xuan Company Ltd.
1,400,000NT$45.2m0%no data
0.4%
Sunshine Protech, Inc.
797,337NT$25.7m0%no data
0.36%
Norges Bank Investment Management
720,474NT$23.2m0%no data
0.16%
Acadian Asset Management LLC
314,000NT$10.1m0%no data
0.038%
Fidelity International Ltd
76,000NT$2.5m0%no data
0.015%
American Century Investment Management Inc
29,987NT$966.9k-0.11%no data
0.0095%
Kuo-Hsiang Chao
19,000NT$612.8k0%no data
0.0018%
Shi Hui Chen
3,607NT$116.1k0%no data
0.00089%
Chieh-Han Lee
1,784NT$57.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 21:59
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Taiyen Biotech Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullE.Sun Securities Investment Consulting Co. Ltd.
Titan HorngIBTS Investment Consulting Co., Ltd.
Zhennan LeeJih Sun Securities Investment Consulting Co., Ltd.